Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Guelph

$27,000.00

Aberrant neurodevelopment in schizophrenia: Contributions from Leucine-rich, Glioma Inactivated 1 (LGI1), R-spondins, and Wnt signaling?

FY 2024-25

Summary
Although the symptoms of schizophrenia typically appear during late adolescence, the cellular processes underlying it begin before birth. Our lab found that levels of a protein called Leucine-rich, Glioma Inactivated 1 (LGI1) were lower in schizophrenia patient-derived cerebral organoids (mini-brains) than those from healthy controls. Mutations in LGI1 cause the neurodevelopmental disorder epilepsy and LGI1 was recently associated with the Wnt signaling pathway, which is thought to be dysregulated in schizophrenia. Other groups have observed altered proliferation of neural progenitors in schizophrenia cerebral organoids, and Wnt signaling is known to regulate proliferation.Therefore, I hypothesize that LGI1 is contributing to altered neurodevelopment in patients with schizophrenia through the Wnt signaling pathway, causing changes in the proliferation of neural progenitors that can influence neurons in the mature brain. To test this, I will explore if activation of the Wnt signaling pathway is altered when LGI1 protein is added to the culture media of neural progenitors. I will also explore if proliferation is increased in neural progenitors that cannot express LGI1, which would suggest that LGI1 can inhibit proliferation. Finally, I will compare cerebral organoids from schizophrenia patients to those from healthy individuals and look at where the expression of LGI1 is different. I predict I will see this difference in the inner, neural progenitor-containing areas, indicating that dysregulation of LGI1 may occur early in neurodevelopment in cells that could affect the brain function of patients later in life.This research will explore cellular aspects of schizophrenia that are difficult to observe in humans, which may provide insight into more effective treatments.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529710
Name
Chartley Ellis
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Aberrant neurodevelopment in schizophrenia: Contributions from Leucine-rich, Glioma Inactivated 1 (LGI1), R-spondins, and Wnt signaling?
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Signaling; Cerebral Organoids; Crispr-Cas13 Rna Knockdown; Immunofluorescence; Neural Progenitor Cells; Neurodevelopment; Proliferation; Schizophrenia
Abstract
Although the symptoms of schizophrenia typically appear during late adolescence, the cellular processes underlying it begin before birth. Our lab found that levels of a protein called Leucine-rich, Glioma Inactivated 1 (LGI1) were lower in schizophrenia patient-derived cerebral organoids (mini-brains) than those from healthy controls. Mutations in LGI1 cause the neurodevelopmental disorder epilepsy and LGI1 was recently associated with the Wnt signaling pathway, which is thought to be dysregulated in schizophrenia. Other groups have observed altered proliferation of neural progenitors in schizophrenia cerebral organoids, and Wnt signaling is known to regulate proliferation.Therefore, I hypothesize that LGI1 is contributing to altered neurodevelopment in patients with schizophrenia through the Wnt signaling pathway, causing changes in the proliferation of neural progenitors that can influence neurons in the mature brain. To test this, I will explore if activation of the Wnt signaling pathway is altered when LGI1 protein is added to the culture media of neural progenitors. I will also explore if proliferation is increased in neural progenitors that cannot express LGI1, which would suggest that LGI1 can inhibit proliferation. Finally, I will compare cerebral organoids from schizophrenia patients to those from healthy individuals and look at where the expression of LGI1 is different. I predict I will see this difference in the inner, neural progenitor-containing areas, indicating that dysregulation of LGI1 may occur early in neurodevelopment in cells that could affect the brain function of patients later in life.This research will explore cellular aspects of schizophrenia that are difficult to observe in humans, which may provide insight into more effective treatments.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chartley, Ellis
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~